// App-Quantinova.ai

AB1204 : COST-EFFECTIVENESS OF ABATACEPT IN SPAIN IN SEROPOSITIVE BIOLOGIC-NAÏVE EARLY RHEUMATOID ARTHRITIS PATIENTS WITH SHARED EPITOPE

Researchers

Presenter

  • J. M. Rodrguez-Heredia

Principal Investigators

  • L. Verburg-Baltussen

  • D. Devender

  • N. Durno

  • C. Sanchez

  • N. Ray

  • M. Treur

  • J. Zhuo

Medical Centers

  • Hospital Universitario de Getafe, Getafe, Spain

  • Pharmerit International, Rotterdam, Netherlands

  • Bristol-Myers Squibb Company, Lawrencville, NJ, United States of America

  • Pharmerit International, Oxford, United Kingdom

  • Bristol-Myers Squibb, Madrid, Spain

Locations

  • Spain

  • Netherlands

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved